www.neurotoxindecisions.com

Continuing Medical Education

Intended Audience

This activity was developed for dermatologists, plastic surgeons, and core cosmetic physicians who use neurotoxins in facial cosmetic enhancements.

Statement of Need

The aesthetic use of neurotoxins is commonplace in many cosmetic dermatology practices in the United States. Despite the number of procedures, which increases each year, the use of advanced injection techniques based on individual facial features is a relatively new concept. Additionally, the recent FDA approval of a new neurotoxin offers clinicians and their patients another option to consider in determining the optimal treatment based on safety and efficacy. Differences in long-term effect, reconstitution, dosing, and possibly field of effect require an understanding of the clinical utility of this new agent. This 2-hour on-demand program offers participants keen insights into achieving optimal results with neurotoxins, based on understanding of muscle kinesiology, differences in pharmacokinetics, and injection techniques. Key recommendations and guidance from a recently held international consensus conference will be featured.

Back to Top

Learning Objectives

Upon completion of this activity, participants should be able to:

Explain the scientific differences between neurotoxin agents, including basic structure, mechanism of action, and the science of unmasking
Outline neurotoxin clinical trials performed in the United States and internationally that may help clinicians in their understanding of the similarities and differences between available agents, including pharmacokinetics, key facial muscle kinesiology, indications and contraindications, reconstitution and storage, dosing, injection, diffusion, and long-term effect
Describe the importance of dosing ranging in various facial areas and its potential impact on effectiveness
Demonstrate proficiency in communicating with patients to establish appropriate outcomes and ensure patient satisfaction; discuss multimodal approaches to cosmetic enhancement
Articulate key recommendations and guidance from the International Consensus Conference on the Use of Neurotoxins in Facial Aesthetics

Back to Top

Accreditation and Certification

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Annenberg Center for Health Sciences at Eisenhower and ContinuED Medical, LLC. The Annenberg Center is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

There is no charge for this activity. To obtain a certificate of credit for 2.0 Category 1 credits, you must register online, view the presentation, complete the online CME activity post-test, and receive a score of 70% or better on the 10-question post-test.

Back to Top

Disclosure

It is the policy of the Annenberg Center to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any significant relationship with those supporting the activity or any others whose products or services are discussed.

Back to Top

Faculty

Gary D. Monheit, MD (Program Chair)
Associate Clinical Professor, Departments of Dermatology and Ophthalmology
University of Alabama Medical Center
Private Practice, Total Skin and Beauty Dermatology Center, PC
Birmingham, Alabama, USA

Consultant: Allergan, Inc, ColBar, Johnson & Johnson, Electro-Optical Sciences, Inc, Galderma, Genzyme Corporation, Ipsen, Medicis Pharmaceutical Corporation, Mentor Corporation, Revance Therapeutics, Inc, Stiefel Laboratories, Inc

Research Support: Allergan, Inc, ColBar, Johnson & Johnson, Contura International A/S, Dermik Laboratories, Electro-Optical Sciences, Inc, Genzyme Corporation, Ipsen, Kythera Biopharmaceuticals, Inc, Medicis Pharmaceutical Corporation

Mitchel P. Goldman, MD
Voluntary Clinical Professor of Dermatology/Medicine
University of California, San Diego
Founder and Medical Director, Dermatology/Cosmetic Laser Associates of La Jolla, Inc
La Jolla, California, USA

Consultant: Allergan, Inc, Medicis Pharmaceutical Corporation, Mentor Corporation

Research Support: Allergan, Inc, Medicis Pharmaceutical Corporation, Mentor Corporation, Ortho Dermatologics

Ava Shamban, MD
Assistant Clinical Professor of Dermatology
David Geffen School of Medicine at UCLA
Los Angeles, California, USA
Private Practice, Laser Institute for Dermatology and European Skin Care
Santa Monica, California, USA

Consultant: Allergan, Inc, Medicis Pharmaceutical Corporation, Ortho Dematologics

Research Support: Galderma, Medicis Pharmaceutical Corporation, Ortho Dermatologics, Stiefel Laboratories Inc.

Speakers Bureau: Allergan, Inc, Medicis Pharmaceutical Corporation, Ortho Dermatologics

Back to Top

Additional Content Planners

Kraig Johnson and John Russo, Jr., PharmD (medical writer) have nothing to disclose.

All staff at the Annenberg Center for Health Sciences at Eisenhower have nothing to disclose.

The faculty for this activity has disclosed that there will be discussion about the use of products for non-FDA approved indications.

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient's unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

This activity is an enduring material and consists of a Web activity. Successful completion is achieved by reading and viewing the material, reflecting on its implications in your practice, and completing the assessment component. The estimated time to complete the activity is 2 hours.

This was originally released in November 2009 and is eligible for credit through November 2011.

If you have questions about this activity please send an e-mail to neurotoxindecisions@edu-meetings.com.

Back to Top

Acknowledgement

This activity is supported by an independent educational grant from Medicis Pharmaceutical Corporation.

Back to Top

Privacy Statement

The Annenberg Center for Health Sciences and ContinuED Medical, LLC respects your privacy. We don't share information you give us, or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission.

Back to Top

Registration, Evaluation, Post-Test and Certificate Request Forms

Registration for educational programs or conferences typically requires some personal information necessary to issue a Continuing Education certificate. This information is required regardless of the method used to register. Personal data collected for this purpose is not shared with others except as required to complete the requested certificate. Aggregate data about registrations and certificates issued may be shared with faculty, supporting organizations, or others, but individual identifying information is not included in these data sets.

Back to Top

Internet Privacy Information

For more information about privacy online, cookies, and what a Web server can and cannot learn about you without your cooperation, visit the Center for Democracy and Technology's Privacy page at: http://www.cdt.org/privacy/.

Back to Top

Copyright Policy

The Annenberg Center for Health Sciences and ContinuED Medical, LLC owns the copyright for, or has received permissions for use of, or is otherwise permitted to use copyrighted materials within this CE activity. You may not modify copy, reproduce, republish, upload, post, transmit, or distribute in any way any material from this Web site, including code and software. You may use material from this site for your personal, noncommercial use only, provided you keep intact all copyright and other proprietary notices.

Back to Top

Log In


Continuing Medical Education Intended Audience This activity was developed for dermatologists, plastic surgeons, and core cosmetic physicians who use neurotoxins in facial cosmetic enhancements. Statement of Need The aesthetic use of neurotoxins is commonplace in many cosmetic dermatology practices in the United States. Despite the number of procedures, which increases each year, the use of advanced injection techniques based on individual facial features is a relatively new concept. Additionally, the recent FDA approval of a new neurotoxin offers clinicians and their patients another option to consider in determining the optimal treatment based on safety and efficacy. Differences in long-term effect, reconstitution, dosing, and possibly field of effect require an understanding of the clinical utility of this new agent. This 2-hour on-demand program offers participants keen insights into achieving optimal results with neurotoxins, based on understanding of muscle kinesiology, differences in pharmacokinetics, and injection techniques. Key recommendations and guidance from a recently held international consensus conference will be featured. Back to Top Learning Objectives Upon completion of this activity, participants should be able to: Explain the scientific differences between neurotoxin agents, including basic structure, mechanism of action, and the science of unmasking Outline neurotoxin clinical trials performed in the United States and internationally that may help clinicians in their understanding of the similarities and differences between available agents, including pharmacokinetics, key facial muscle kinesiology, indications and contraindications, reconstitution and storage, dosing, injection, diffusion, and long-term effect Describe the importance of dosing ranging in various facial areas and its potential impact on effectiveness Demonstrate proficiency in communicating with patients to establish appropriate outcomes and ensure patient satisfaction; discuss multimodal approaches to cosmetic enhancement Articulate key recommendations and guidance from the International Consensus Conference on the Use of Neurotoxins in Facial Aesthetics Back to Top Accreditation and Certification This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Annenberg Center for Health Sciences at Eisenhower and ContinuED Medical, LLC. The Annenberg Center is accredited by the ACCME to provide continuing medical education for physicians. The Annenberg Center designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. There is no charge for this activity. To obtain a certificate of credit for 2.0 Category 1 credits, you must register online, view the presentation, complete the online CME activity post-test, and receive a score of 70% or better on the 10-question post-test. Back to Top Disclosure It is the policy of the Annenberg Center to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any significant relationship with those supporting the activity or any others whose products or services are discussed. Back to Top Faculty Gary D. Monheit, MD (Program Chair) Associate Clinical Professor, Departments of Dermatology and Ophthalmology University of Alabama Medical Center Private Practice, Total Skin and Beauty Dermatology Center, PC Birmingham, Alabama, USA Consultant: Allergan, Inc, ColBar, Johnson & Johnson, Electro-Optical Sciences, Inc, Galderma, Genzyme Corporation, Ipsen, Medicis Pharmaceutical Corporation, Mentor Corporation, Revance Therapeutics, Inc, Stiefel Laboratories, Inc Research Support: Allergan, Inc, ColBar, Johnson & Johnson, Contura International A/S, Dermik Laboratories, Electro-Optical Sciences, Inc, Genzyme Corporation, Ipsen, Kythera Biopharmaceuticals, Inc, Medicis Pharmaceutical Corporation Mitchel P. Goldman, MD Voluntary Clinical Professor of Dermatology/Medicine University of California, San Diego Founder and Medical Director, Dermatology/Cosmetic Laser Associates of La Jolla, Inc La Jolla, California, USA Consultant: Allergan, Inc, Medicis Pharmaceutical Corporation, Mentor Corporation Research Support: Allergan, Inc, Medicis Pharmaceutical Corporation, Mentor Corporation, Ortho Dermatologics Ava Shamban, MD Assistant Clinical Professor of Dermatology David Geffen School of Medicine at UCLA Los Angeles, California, USA Private Practice, Laser Institute for Dermatology and European Skin Care Santa Monica, California, USA Consultant: Allergan, Inc, Medicis Pharmaceutical Corporation, Ortho Dematologics Research Support: Galderma, Medicis Pharmaceutical Corporation, Ortho Dermatologics, Stiefel Laboratories Inc. Speakers Bureau: Allergan, Inc, Medicis Pharmaceutical Corporation, Ortho Dermatologics Back to Top Additional Content Planners Kraig Johnson and John Russo, Jr., PharmD (medical writer) have nothing to disclose. All staff at the Annenberg Center for Health Sciences at Eisenhower have nothing to disclose. The faculty for this activity has disclosed that there will be discussion about the use of products for non-FDA approved indications. The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient's unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented. This activity is an enduring material and consists of a Web activity. Successful completion is achieved by reading and viewing the material, reflecting on its implications in your practice, and completing the assessment component. The estimated time to complete the activity is 2 hours. This was originally released in November 2009 and is eligible for credit through November 2011. If you have questions about this activity please send an e-mail to neurotoxindecisions@edu-meetings.com. Back to Top Acknowledgement This activity is supported by an independent educational grant from Medicis Pharmaceutical Corporation. Back to Top Privacy Statement The Annenberg Center for Health Sciences and ContinuED Medical, LLC respects your privacy. We don't share information you give us, or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission. Back to Top Registration, Evaluation, Post-Test and Certificate Request Forms Registration for educational programs or conferences typically requires some personal information necessary to issue a Continuing Education certificate. This information is required regardless of the method used to register. Personal data collected for this purpose is not shared with others except as required to complete the requested certificate. Aggregate data about registrations and certificates issued may be shared with faculty, supporting organizations, or others, but individual identifying information is not included in these data sets. Back to Top Internet Privacy Information For more information about privacy online, cookies, and what a Web server can and cannot learn about you without your cooperation, visit the Center for Democracy and Technology's Privacy page at: http://www.cdt.org/privacy/. Back to Top Copyright Policy The Annenberg Center for Health Sciences and ContinuED Medical, LLC owns the copyright for, or has received permissions for use of, or is otherwise permitted to use copyrighted materials within this CE activity. You may not modify copy, reproduce, republish, upload, post, transmit, or distribute in any way any material from this Web site, including code and software. You may use material from this site for your personal, noncommercial use only, provided you keep intact all copyright and other proprietary notices. Back to Top